000 | 03083nam a22005535i 4500 | ||
---|---|---|---|
001 | 978-88-470-0391-0 | ||
003 | DE-He213 | ||
005 | 20161121230744.0 | ||
007 | cr nn 008mamaa | ||
008 | 100301s2007 it | s |||| 0|eng d | ||
020 |
_a9788847003910 _9978-88-470-0391-0 |
||
024 | 7 |
_a10.1007/978-88-470-0391-0 _2doi |
|
050 | 4 | _aRC346-429.2 | |
072 | 7 |
_aMJN _2bicssc |
|
072 | 7 |
_aMED056000 _2bisacsh |
|
082 | 0 | 4 |
_a616.8 _223 |
245 | 1 | 0 |
_aNeurodegeneration in Multiple Sclerosis _h[electronic resource] / _cedited by Massimo Filippi, Marco Rovaris, Giancarlo Comi. |
264 | 1 |
_aMilano : _bSpringer Milan, _c2007. |
|
300 |
_aXI, 236 p. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 | _aTopics in Neuroscience | |
505 | 0 | _aBackground -- Neuropathological Advances in Multiple Sclerosis -- Neurophysiology -- MRI Techniques to Assess Neurodegeneration -- Atrophy -- T1 Black Holes and Gray Matter Damage -- Magnetization Transfer Imaging -- Perfusion MR I -- Diffusion-Weighted Imaging -- Proton MR Spectroscopy -- Functional MRI -- Evaluation of MRI Outcomes -- Validation of MRI Surrogates -- Defining Responders and Non-responders -- Predictive Models in Multimodal Imaging -- Lessons from Other Neurodegenerative Diseases -- Alzheimer’s Disease -- Other Neurodegenerative Conditions -- Incorporation of Other Biomarkers -- Designing MS Trials for Neurodegeneration -- Critical Review of Existing Trials -- Design for the Next Trials of Neurodegeneration. | |
520 | _aIn multiple sclerosis (MS), conventional magnetic resonance imaging (cMRI) has proved to be a valuable tool to increase diagnostic reliability and to monitor the efficacy of experimental treatment. However, cMRI has limited specificity and accuracy as to the most disabling aspects of the MS pathology, known to occur in and outside macroscopic lesions. Modern quantitative MR techniques have the potential to overcome the limitations of cMRI, and their application is dramatically changing our understanding of how MS causes irreversible disability. Written by world-renowned scientists, the volume is indispensable for anybody working in this field. | ||
650 | 0 | _aMedicine. | |
650 | 0 | _aNeurosciences. | |
650 | 0 | _aRadiology. | |
650 | 0 | _aNeuroradiology. | |
650 | 0 | _aNuclear medicine. | |
650 | 0 | _aNeurology. | |
650 | 1 | 4 | _aMedicine & Public Health. |
650 | 2 | 4 | _aNeurology. |
650 | 2 | 4 | _aNeurosciences. |
650 | 2 | 4 | _aImaging / Radiology. |
650 | 2 | 4 | _aNeuroradiology. |
650 | 2 | 4 | _aNuclear Medicine. |
700 | 1 |
_aFilippi, Massimo. _eeditor. |
|
700 | 1 |
_aRovaris, Marco. _eeditor. |
|
700 | 1 |
_aComi, Giancarlo. _eeditor. |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer eBooks | |
776 | 0 | 8 |
_iPrinted edition: _z9788847003903 |
830 | 0 | _aTopics in Neuroscience | |
856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-88-470-0391-0 |
912 | _aZDB-2-SME | ||
950 | _aMedicine (Springer-11650) | ||
999 |
_c503493 _d503493 |